ClinicalTrials.gg
CompletedNCT05740332Updated Sep 4, 2024Results posted

Wet Time for a Foam Hand Sanitizer

A Phase 4 interventional study of Alcohol hand sanitizer foam in Hand Hygiene Effectiveness, sponsored by Medline Industries. Completed at 1 site in United States. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-04.

Sponsored by Medline Industries · Phase 4, Interventional, and Other

Phase
Phase 4
Study type
Interventional
Enrollment
46
Allocation
Not applicable
Ages
18 Years to 99 Years
Sex
All
01

Study summary

Hand sanitizers are a standard of hygiene requirements. They must be effective at reducing germ count on the hands while ideally providing emollients to moisturize the skin after use. Spectrum™ Advanced Hand Sanitizer Foam (70%) (hereby referred to as Spectrum Advanced Foam) kills over 99.99% of germs within 15 seconds while boasting double digit increases in hand moisture after two weeks of use.

In 2002 and 2009 the Center for Disease Control and Prevention (CDC) and World Health Organization (WHO) published guidance that hands should remain wet for at least 15 seconds while being rubbed together after application of an alcohol-based hand rub, though the recommendations do not specify the volume of product to be apply.

This study will evaluate the "wet time" of Spectrum Advanced Foam, which will be defined as the length of time in which the sanitizer foam stays wet on the hands while the participant rubs their hands with the foam sanitizer. The participant will first be asked to wash and dry their hands. Participants will review the appropriate hand sanitizer application steps, as detailed by the WHO guidance. Then, a 1.0 milliliter (mL) aliquot of Spectrum Advanced Foam will be dispensed from an automated dispenser to the participant's hands. The participant will be asked to rub their hands together following the WHO method for hand sanitizer application until they declare the product has dried sufficiently for the donning of medical gloves. Study personnel will measure the wet time of Spectrum Advanced foam using a stopwatch. If the 1.0 ml aliquot does not yield sufficient results to meet WHO guidelines then a 1.4 ml aliquot will be tested, however this was not the case for our study.

Read the detailed description

Hand sanitizers are a standard of hygiene requirements. They must be effective at reducing germ count on the hands while ideally providing emollients to moisturize the skin after use. In 2002 and 2009 the CDC and WHO published guidances that hands should remain wet for at least 15 seconds while being rubbed together after application of an alcohol-based hand rub, though the recommendations do not specify the volume of product to be apply. The CDC specifically recommends applying alcohol-based hand sanitizers by applying the manufacturer-recommended amount of sanitizer directly to the palm of one hand and then rubbing the hands together. The sanitizer must entirely cover the surfaces of both hands and all fingers while rubbing the hands together until the product has dried. The goal of this study is to evaluate the "wet time" of Spectrum Advanced Foam, which will be defined in this study as the length of time in which the foam sanitizer stays wet on the hands while the participant rubs their hands with the foam sanitizer.

02

Conditions studied

  • Hand Hygiene Effectiveness
03

In context

Lead sponsor

Medline Industries is the lead sponsor of 39 studies on the registry; none are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 14 (93%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individual ≥ 18 years of age

Exclusion criteria

Exclusion Criteria:

  • Individual has a self reported skin condition that might result in irritation from the hand sanitizer.
  • Individual has a known allergy to the ingredients in the test product.
05

Study design

Phase
Phase 4
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
46 participants (actual)

Study arms

  • Experimental
    All participants

    1 mL of alcohol foam hand sanitizer automatically dispensed into hands, spread over hands and rubbed until dry.

    Drug: Alcohol hand sanitizer foam

Interventions

  • DrugAlcohol hand sanitizer foam

    1mL of alcohol foam hand sanitizer automatically dispensed into hands, spread over hands and rubbed until dry. Other Name: Medline Spectrum™ Advanced Hand Sanitizer Foam (70%)

06

What researchers measure

Primary outcomes

  1. Foam Sanitizer Wet Time Duration

    To determine the duration of time during which a 1.0 mL aliquot of Spectrum Advanced Hand Sanitizer Foam remains wet under conventional use conditions.

    Time frame: 2 mins

07

Results

Posted Sep 4, 2024

Participant flow

Participant flow — Overall Study
MilestoneAll Participants
Started46
Completed46
Not completed0

Outcome measures

PrimaryFoam Sanitizer Wet Time Duration

To determine the duration of time during which a 1.0 mL aliquot of Spectrum Advanced Hand Sanitizer Foam remains wet under conventional use conditions.

Time frame:
2 mins
Reported as:
Mean · time in seconds
Foam Sanitizer Wet Time Duration
time in secondsAll Participants
Foam Sanitizer Wet Time Duration35.41 ± 13.51

Adverse events

Collected over 4 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
All Participants0/46 (0%)0/46 (0%)0/46 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)All Participants
Mean34.6 (23 to 59)
Sex: Female, Male
Sex: Female, Male(Participants)All Participants
Female30
Male16
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)All Participants
08

Study locations

1 site
  • Medline Industries, LP
    Northfield, Illinois 60093, United States
09

References and documents

Publications

  • Boyce JM, Pittet D; Healthcare Infection Control Practices Advisory Committee; HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep. 2002 Oct 25;51(RR-16):1-45, quiz CE1-4. PubMed 12418624 ↗
  • WHO Guidelines on Hand Hygiene in Health Care: First Global Patient Safety Challenge Clean Care Is Safer Care. Geneva: World Health Organization; 2009. Available from http://www.ncbi.nlm.nih.gov/books/NBK144013/ PubMed 23805438 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Dec 2022 to primary completion in Jan 2023, 1 month.

Results were first posted in Sep 2024, 1 year 7 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 13, 2023
First posted
Feb 23, 2023
StartActual
Dec 12, 2022
Primary completionActual
Jan 12, 2023
CompletionActual
Jan 12, 2023
Results first posted
Sep 4, 2024
Last update
Sep 4, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05740332
Lead sponsor
Medline Industries
Responsible party
Sponsor
First posted
Feb 23, 2023
Start date
Dec 12, 2022
Primary completion
Jan 12, 2023
Completion
Jan 12, 2023
Results posted
Sep 4, 2024
Last update
Sep 4, 2024

Oversight

FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion